TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS

Conversion of the incurable disease in the chronic form and improvement of the life quality parameters on the background of appearance of new drugs is of specific importance for patients with NSCLC with activating mutations. “ESMO thinks that treatment of patients with wide-spread and incurable canc...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: T. Y. SEMIGLAZOVA, A. S. ZHABINA, А. V. BELYAEVA, V. A. KLUGE, K. V. USOVA, D. H. LATIPOVA, G. M. TELETAEVA, A. V. NOVIK, A. I. SEMENOVA, S. A. PROTSENKO
Format: Artigo
Langue:Russo
Publié: Remedium Group LLC 2016-12-01
Collection:Медицинский совет
Sujets:
itk egfr
pfs
quality of life
nsclc mut +
afatinib
Accès en ligne:https://www.med-sovet.pro/jour/article/view/1406
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires